Mandana Kamgar
7PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.Mandana Kamgar, G Aaron Hobbes, Raven Davidson
|Sep 10, 2025
Bridging the Gap: Molecular Profiling to Guide Treatment Selection in Metastatic Pancreatic Cancer.Mandana Kamgar, Andrew H Ko
|May 21, 2024
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series.Maahum Mehdi, Aniko Szabo, Aditya Shreenivas
|Dec 23, 2023
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.Saryleine de Ortiz de Choudens, Alexis Visotcky, Anjishnu Banerjee
|Jun 10, 2022
Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities.Sakti Chakrabarti, Mandana Kamgar, Amit Mahipal
|Aug 14, 2021
Prevalence and predictors of peripheral neuropathy after breast cancer treatment.Mandana Kamgar, Mark K Greenwald, Hadeel Assad
Pageof 2
Frequent Collaborators
2 joint publications
Sakti Chakrabarti
2 joint publications
Amit Mahipal
2 joint publications
William Hall
2 joint publications
Susan Tsai
1 joint publications
Mark K Greenwald
1 joint publications
Hadeel Assad
1 joint publications
Theresa A Hastert
1 joint publications
Eric M McLaughlin
1 joint publications
Thomas McFall
1 joint publications
Electra D Paskett
